EYEGATE PHARMACEUTICALS INC 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jul 19, 2016
Insider Transaction Report
Form 4
Brenneman Ryan Randall
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-07-18+4,568→ 4,568 totalExercise: $2.42Exp: 2026-07-18→ Common Stock (4,568 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 18, 2017, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.